Pathstone Holdings’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $528K | Sell |
104,392
-107,596
| -51% | -$544K | ﹤0.01% | 1699 |
|
|
2025
Q1 | $1.12M | Buy |
211,988
+166,763
| +369% | +$882K | ﹤0.01% | 1321 |
|
|
2024
Q4 | $306K | Sell |
45,225
-4,153
| -8% | -$28.1K | ﹤0.01% | 1960 |
|
|
2024
Q3 | $325K | Buy |
49,378
+1,417
| +3% | +$9.34K | ﹤0.01% | 1928 |
|
|
2024
Q2 | $360K | Buy |
47,961
+676
| +1% | +$5.07K | ﹤0.01% | 1860 |
|
|
2024
Q1 | $471K | Buy |
47,285
+1,258
| +3% | +$12.5K | ﹤0.01% | 1704 |
|
|
2023
Q4 | $454K | Buy |
+46,027
| New | +$454K | ﹤0.01% | 1565 |
|